Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Julie M. Jorns MD
Professor
Department of Pathology
Division of Administration

OFFICE ADDRESS:
Froedtert/MCW Laboratory Building
9200 W Wisconsin Ave
Milwaukee, WI 53226

EDUCATION:
09/1997 - 05/2001 BS, University of Wisconsin at Oshkosh, Oshkosh, WI
08/2001 - 05/2005 MD, Medical College of Wisconsin, Milwaukee, WI

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
07/2005 - 06/2009 Resident, Anatomic and Clinical Pathology, University of Michigan, 1500 E. Medical Center Dr., Ann Arbor, MI 48109
07/2009 - 06/2010 Fellow, Breast Pathology, University of Michigan, 1500 E. Medical Center Dr., Ann Arbor, MI 48109
07/2010 - 06/2011 Fellow, Surgical Pathology, University of Michigan, 1500 E. Medical Center Dr., Ann Arbor, MI 48109

FACULTY APPOINTMENTS:
07/2011 - 06/2017 Assistant Professor of Pathology, University of Michigan Hospital and Health Systems, 1500 E. Medical Center Dr., Ann Arbor, MI 48109
07/2017 - Present Associate Professor of Pathology, Medical College of Wisconsin, 9200 W. Wisconsin Ave., Milwaukee, WI 53226

ADMINISTRATIVE APPOINTMENTS:
2017 - Present Director of Breast Pathology, Medical College of Wisconsin, 9200 W. Wisconsin Ave., Milwaukee, WI 53226
2021 - Present Director of Surgical Pathology, Medical College of Wisconsin, 9200 W. Wisconsin Ave., Milwaukee, WI 53226

EDUCATIONAL ADMINISTRATIVE APPOINTMENTS:
2011 - 2017 Breast Pathology Course Director, medical student (M2) reproductive sequence; University of Michigan, 1500 E. Medical Center Dr., Ann Arbor, MI 48109
2011 - 2017 Surgical Pathology Fellowship Selection Committee, University of Michigan, 1500 E. Medical Center Dr., Ann Arbor, MI 48109
2013 - 2017 Breast Pathology Fellowship Director, University of Michigan, 1500 E. Medical Center Dr., Ann Arbor, MI 48109
2018 - Present Women's (Breast and Gynecologic) Pathology Fellowship Director, Medical College of Wisconsin, 9200 W. Wisconsin Ave., Milwaukee, WI 53226

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
American Board of Pathology
08/2010
12/2030
Pathology - Anatomic
08/2010
12/2030
Pathology - Clinical
08/2010
12/2030
   
Licensure
Number Issue DateExpiration
Michigan License
4301086279
08/2010
01/2019
Wisconsin License
66876-20
02/2017
10/2025
    

AWARDS AND HONORS:
1997 - 2000 Varsity Letters; Women's Cross Country and Track and Field, University of Wisconsin Oshkosh
1998 University of Wisconsin Oshkosh Leadership Award
2009 A.J. French Traveling Fellowship; Infectious disease pathology, Armed Forces Institute of Pathology (AFIP)
2013 University of Michigan Clinical Pathology Program of the Year - East Ann Arbor Intraoperative Breast Cancer Management Practice
2017 - 2018 MCW's Outstanding Medical Student Teachers, The Curriculum and Evaluation Committe, Medical College of Wisconsin
2018 - 2019 Faculty Teacher of the Year, Medical College of Wisconsin, Department of Pathology

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
2005 - Present American Society for Clinical Pathology (Member)
2005 - 2017 A. James French Society (Member)
2005 - Present United States and Canadian Academy of Pathology (Member)
2010 - Present College of American Pathologists (Member)
2010 - 2017 Michigan Society of Pathologists (Member)
2020 - Present Wisconsin Society of Pathologists (Member)
2022 - Present Association of Directors of Anatomic and Surgical Pathology (Member)

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Editorial Board
2018 - Present Annals of Diagnostic Pathology
2020 - Present www.PathologyOutlines.com
2021 - 2022 Associate Editor, The Breast Journal
Ad-Hoc Reviewer
2014 - 2017 Annals of Surgical Oncology
2017 - Present International Journal of Surgical Pathology
2017 - 2021 The Breast Journal
2018 - Present The American Journal of Clinical Pathology
2020 - Present Applied Immunohistochemistry and Molecular Morphology

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Prior
Peer Review
Title:
Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps
Role & Effort:
Co-Investigator
PI:
Anne Schott, MD
Dates:
2016 - Present
  
Title:
A multimodal scanning microscope for intraoperative assessment of breast tumor margins
Source:
GHR, WE Care
Role & Effort:
Co-Investigator
PI:
Bing Yu, PhD
Dates:
2017 - 2021
  
Title:
A Phase II Study of MRI-Based Pre-Operative Accelerated Partial Breast Irradiation
Source:
The Dr. Nancy Laning Sobczak Award for Breast Cancer
Role & Effort:
Co-Investigator
PI:
Adam Currey, MD
Dates:
2017 - 2020
  
Title:
An Exploratory Study of Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive HER2-Negative Node-Negative Breast Cancer Patients to Assess Responses and Mechanisms of Endocrine Resistance
Source:
Rock River Foundation and the MCW Cancer Center
Role & Effort:
Co-Investigator
PI:
Lubna Chaudhary, MD, MS
Dates:
2018 - 2020
  
Title:
Phase II study of PD-1 inhibition in locally advanced hormone receptor (HR) positive HER2 positive or triple negative breast cancer patients undergoing standard neoadjuvant chemotherapy (NAC)
Source:
Advancing a Healthier Wisconsin Research and Education Program (AHW REP) MCW CTSI Mentored Career Development Award KL2 grant
Role & Effort:
Co-Investigator
PI:
Lubna Chaudhary, MD, MS
Dates:
2020 - 2021
  

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
International
Klein K, Zeeb L, Patterson SK, Jorns JM, Flat epithelial atypia: Underestimation rate and pathologic correlation, American Roentegen Ray Society, Annual Meeting, Vancouver, BC, 05/04/2012
 
National
Jorns JM, Visscher D, Sabel MS, Breslin T, Healy P, Daignault S, Myers JL, Wu AJ, Intraoperative Frozen Section Analysis of Margins in Breast Conserving Surgery Significantly Decreases Reoperative Rates: One-Year Experience at an Ambulatory Surgical Center, United States and Canadian Academy of Pathology, Annual Meeting, San Antonio, TX, 02/26/2011 - 03/04/2011
Mor-Vaknin N, Saha AK, Legendre M, Gonzalez-Hernandez MJ, Asif Amin M, Rabquer BJ, Jorns JM, Kaplan MJ, Adams BS, Fox DA, Koh AE, Markovitz D, The DEK autoantigen regulates formation of Neutrophil Extracellular Traps and Zymosan Induced Arthritis in Mice, American College of Rheumatology, Annual Meeting, November, 2012, 11/2012
Marchesan JT, Gerow EA, Schaff R, Taut AD, Shin SY, Sugai J, Brand D, Burberry A, Jorns JM, Lundy SK, Nunez G, Fox DA, Giannobile WV, Chronic Oral Infection Exacerbates the Development and Severity of Collagen-Inducted Arthritis via TH17 Cell Responses, International Association for Dental Research, Annual Meeting, San Francisco, CA, 03/2013
Jorns JM, Breast Atypias, University of Colorado, Anschutz campus, Visiting Professor, Denver, CO, 02/09/2017 - 02/10/2017
Jorns JM, Breast Pathology Unknowns, University of Colorado, Anschutz Campus, Visiting Professor, Denver, CO, 02/09/2017 - 02/10/2017
Savage JL, Jeffries DO, Noroozian M, Sabel MS, Jorns JM, Helvie MA, Pleomorphic LCIS: Imaging Features, Upgrade Rate, and Clinical Outcomes, Society of Breast Imaging, Annual Conference, Los Angeles, CA, 04/06/2017
Moreno G, Molina M, Wu R, Sullivan JR, Jorns JM, Unveiling the Histopathologic Spectrum of MRI-Guided Breast Biopsies: An Institutional Pathological-Radiological Correlation, United States and Canadian Academy of Pathology, Annual Meeting, Los Angeles, CA, 02/29/2020 - 03/05/2020
Wang L, Asirvatham JR, Ma Y, Reisenbichler ES, Jorns JM, HER-2/neu-Positive Breast Cancer Neoadjuvant Chemotherapy Response After Implementation of 2018 ASCO/CAP Focused Update, United States and Canadian Academy of Pathology, Annual Meeting, Virtual, 03/13/2021 - 03/18/2021
Asirvatham JR, Jorns JM, Pathologic Assessment of Axillary Lymph Nodes in Breast Cancer and Implications for Current Clinical Management, United States and Canadian Academy of Pathology (short course), Los Angeles, CA, 03/19/2022 - 03/24/2022
Jorns JM, Breast Pathology Unknowns, The Ohio State University (grand rounds), Columbus, OH, 09/30/2022 - Present
Jorns JM, Breast Cancer Following Neoadjuvant Therapy, The Ohio State University (grand rounds), Columbus, OH (rescheduled from virtual date 06/17/2022), 09/30/2022
Jorns JM, Breast Pathology: Parts I and II, United States and Canadian Academy of Pathology / Pearls and Palms in Surgical Pathology (interactive microscopy course), Palm Springs, CA (rescheduled from orignal dates in May 2022), 10/12/2022 - 10/15/2022
 
Regional
Nees A, Jorns JM, Metaplastic carcinoma of the breast: imaging and histopathologic correlation, Radiological Society of North America Annual Meeting, Chicago, IL, 12/2009
Jorns JM, Intraoperative Evaluation of Lumpectomy Margins, Bronson Battle Creek Cancer Symposium, Battle Creek, MI, 10/12/2013
Jorns JM, Breast frozen sections at the University of Michigan, Munson Medical Center Visiting Professor, Traverse City, MI, 08/11/2016 - 08/12/2016
Jorns JM, Evolution of breast cancer treatment in the last decade: How it has influenced pathology, Munson Medical Center Visiting Professor, Traverse City, MI, 08/11/2016 - 08/12/2016
Jorns JM, Papillary Lesions of the Breast, William Beaumont Hospital Visiting Professor, Royal Oak, MI, 09/13/2016
Rui H, Jorns JM, Updates in Programmed Death Receptor 1 (PD-1) in Breast Cancer, Wisconsin Society of Pathologists annual meeting, Pewaukee, WI, 04/27/2019 - Present
Jorns JM, Standardizing Cold Ischemia Time, Uuniversity of Wisconsin Madison Clinical Rounds in Surgical Pathology, Virtual, 04/18/2022 - Present
 
Local
Sabel MS, Jorns JM, Controversies in breast pathology: Intraoperative frozen section analysis of lumpectomy margins, New Frontiers in Pathology Conference, Ann Arbor, MI, 09/30/2010 - 10/02/2010
Jorns JM, Controversies in breast pathology: Sentinel lymph node biopsies, New Frontiers in Pathology Conference, Ann Arbor, MI, 10/12/2011 - 10/15/2011
Jorns JM, Lobular neoplasia: Morphology and management, New Frontiers in Pathology Conference, Ann Arbor, MI, 09/25/2013 - 09/28/2013
Jorns JM, Histology 101 & A Little Breast Pathology and how it Affects You, University Michigan Operating Room Staff Continuing Medical Education Series, Ann Arbor, MI, 03/20/2014
Jorns JM, Multiple Myeloma Presenting as a Breast Mass Mimicking Invasive Lobular Carcinoma, New Frontiers in Pathology Conference, Ann Arbor, MI, 09/03/2014 - 09/06/2014
Sabel MS, Jorns JM, Recent Consensus Guidelines on Margins for Breast-Conserving Surgery, New Frontiers in Pathology Conference, Ann Arbor, MI, 09/03/2014 - 09/06/2014
Jorns JM, Papillary Lesions of the Breast: A Practical Approach to Diagnosis, New Frontiers in Pathology Conference, Ann Arbor, MI, 10/21/2015 - 10/24/2015
Patterson SK, Jorns JM, Localization for Surgery: The Next Generation, New Frontiers in Pathology Conference, Ann Arbor, MI, 10/12/2016 - 10/15/2016
Jorns JM, Cold Ischemic Time, Froedtert and the Medical College of Wisconsin Operating Room Continuing Medical Education Series, Milwaukee, WI, 05/04/2018
Jorns JM, Breast Cancer Biomarkers, Midwestern Conference Update Course in Diagnostic Pathology, Milwaukee, WI, 09/14/2018 - 09/16/2018
Patton M, Jorns JM, Cold Ischemic Time and Specimen Requirements, Froedtert and the Medical College of Wisconsin Operating Room Continuing Medical Education Series, Milwaukee, WI, 10/20/2021
Jorns JM, Cold Ischemic Time: Implications for Breast Cancer Patients and Beyond, 13th Annual Midwestern Conference: Update Course in Diagnostic Pathology, Milwaukee, WI, 09/23/2022 - 09/25/2022
Jorns JM, Breast Primary of Gynecologic Metastasis?, 13th Annual Midwestern Conference: Update Course in Diagnostic Pathology, Milwaukee, WI, 09/23/2022 - 09/25/2022
 

COMMITTEE SERVICE:
Medical College of Wisconsin
2017 - 2019 Pathology Department Liaison, Medical School, Medical College of Wisconsin
2017 - 2018 Member, Laboratory Quality Committee, Anatomic Pathology, Pathology, Medical College of Wisconsin
2018 - Present Chair, Laboratory Quality Committee, Anatomic Pathology, Pathology, Medical College of Wisconsin
2019 - 2024 Member, Education Committee, Pathology, Medical College of Wisconsin
 
Hospital
2012 - 2017 Pathology Representative, Cancer Working Group, University of Michigan
2013 - 2017 Pathology Representative, Breast Cancer Task Force, University of Michigan
2017 - Present Pathology Representative, Breast Steering Committee, Medical College of Wisconsin
2017 - Present Pathology Representative, Faculty Hospital Cancer Committee, Medical College of Wisconsin
2018 - Present Pathology Representative, Patient Safety Quality Officer (PSQO), Medical College of Wisconsin
2021 - 2022 Breast Surgeon Search Committee, Medical College of Wisconsin
 

MCW TEACHING ACTIVITIES:
Medical Student Education
2003 Tutor, Cell and Tissue Biology and Neuroanatomy
2018 - 2019 Faculty Lecturer, M2 Reproductive Sequence, Breast Pathology
 
Resident and Fellow Education
2017 - Present Resident and Fellow Educator
2018 - Present Director, Women's (Breast and Gynecologic) Pathology Fellowship
 
Community/Lay Public
2001 - 2005 HIV/AIDS Prevention Educator; Medical College of Wisconsin Council on AIDS Reaching Out and Educating Students (MCW Cares) for high school-aged students (President 2002-2003)
2001 - 2003 "Tar Wars" Anti-Smoking Educator, national anti-smoking campaign for elementary-aged students
 

EXTRAMURAL TEACHING:
Medical Student Education
2011 - 2017 University of Michigan, Faculty Lecturer, M2 Reproductive Sequence, Breast Pathology
2011 - 2017 University of Michigan, Faculty Lecturer, M1 Pathology Laboratory Sequence
 
Resident and Fellow Education
2005 - 2008 University of Michigan, Resident Lecturer, M1 pathology sequence
2011 - 2017 University of Michigan, Resident and Fellow Educator
 
Community/Lay Public
1999 - 2000 University of Wisconsin Oshkosh, Teaching assistant; Science Outreach Program for elementary and middle school-aged students
2022 - Present Elmwood Elementary School, New Berlin, WI, Jump Into Your Future (career fair)
 


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Sarkar S, Cooney LA, White P, Dunlop DB, Endres J, Jorns JM, Wasco MJ, Fox DA. Regulation of pathogenic IL-17 responses in collagen-induced arthritis: roles of endogenous interferon-gamma and IL-4. Arthritis Res Ther. 2009;11(5):R158. PMCID: PMC2787258
2. Jorns JM, Knoepp SM. Occult fallopian tube carcinoma detected in routine pelvic washing specimens submitted for staging: another justification for pelvic washing cytology? Diagn Cytopathol. 2009 Dec;37(12):923-9.
3. Jorns JM, Knoepp SM. Asteroid bodies in lymph node cytology: infrequently seen and still mysterious. Diagn Cytopathol. 2011 Jan;39(1):35-6.
4. Sabel MS, Jorns JM, Wu A, Myers J, Newman LA, Breslin TM. Development of an intraoperative pathology consultation service at a free-standing ambulatory surgical center: clinical and economic impact for patients undergoing breast cancer surgery. Am J Surg. 2012 Jul;204(1):66-77.
5. Jorns JM, Visscher D, Sabel M, Breslin T, Healy P, Daignaut S, Myers JL, Wu AJ. Intraoperative frozen section analysis of margins in breast conserving surgery significantly decreases reoperative rates: one-year experience at an ambulatory surgical center. Am J Clin Pathol. 2012 Nov;138(5):657-69. PMCID: PMC3988579
6. Butler R, Pinsky R, Jorns JM. Alveolar variant of invasive lobular carcinoma in a fibroadenoma. Breast J. 2012;18(6):613-4.
7. Kehr EL, Jorns JM, Ang D, Warrick A, Neff T, Degnin M, Lewis R, Beadling C, Corless CL, Troxell ML. Mucinous breast carcinomas lack PIK3CA and AKT1 mutations. Hum Pathol. 2012 Dec;43(12):2207-12.
8. Patterson SK, Jorns JM. A case of juvenile papillomatosis, aka "Swiss cheese disease". Breast J. 2013;19(4):440-1.
9. Jorns JM, Healy P, Zhao L. Review of estrogen receptor, progesterone receptor, and HER-2/neu immunohistochemistry impacts on treatment for a small subset of breast cancer patients transferring care to another institution. Arch Pathol Lab Med. 2013 Nov;137(11):1660-3.
10. Marchesan JT, Gerow EA, Schaff R, Taut AD, Shin SY, Sugai J, Brand D, Burberry A, Jorns J, Lundy SK, Nuñez G, Fox DA, Giannobile WV. Porphyromonas gingivalis oral infection exacerbates the development and severity of collagen-induced arthritis. Arthritis Res Ther. 2013 Nov 12;15(6):R186. PMCID: PMC3979094
11. Marchesan J.T., Gerow E.A, Schaff R., Dan Taut A., Shin S.Y., Sugai J., Brand D., Burberry A., Jorns J., Lundy S.K., Nunez G., Fox D.A., Giannobile W.V. Porphyromonas gingivalis oral infection exacerbates the development and severity of collagen-induced arthritis. Arthritis Research & Therapy. 2013; 15:R186.
12. Jorns JM. Nodular papillomatosis in a 12-year-old female. Breast J. 2014;20(4):426-7.
13. Jorns J, Sabel MS, Pang JC. Lobular neoplasia: morphology and management. Arch Pathol Lab Med. 2014 Oct;138(10):1344-9.
14. Jorns JM, Daignault S, Sabel MS, Wu AJ. Is intraoperative frozen section analysis of reexcision specimens of value in preventing reoperation in breast-conserving therapy? Am J Clin Pathol. 2014 Nov;142(5):601-8.
15. Jorns JM, Thomas DG, Healy PN, Daignault S, Vickery TL, Snider JE, Mardis ER, Davies SR, Ellis MJ, Visscher DW. Estrogen receptor expression is high but is of lower intensity in tubular carcinoma than in well-differentiated invasive ductal carcinoma. Arch Pathol Lab Med. 2014 Nov;138(11):1507-13. PMCID: PMC4327939
16. Arps DP, Jorns JM, Zhao L, Bensenhaver J, Kleer CG, Pang JC. Re-excision rates of invasive ductal carcinoma with lobular features compared with invasive ductal carcinomas and invasive lobular carcinomas of the breast. Ann Surg Oncol. 2014 Dec;21(13):4152-8.
17. Walters LL, Pang JC, Zhao L, Jorns JM. Ductal carcinoma in situ with distorting sclerosis on core biopsy may be predictive of upstaging on excision. Histopathology. 2015 Mar;66(4):577-86.
18. Ishikawa MK, Pinsky RW, Smith LB, Jorns JM. Morphologic Mimics of Invasive Lobular Carcinoma. Arch Pathol Lab Med. 2015 Oct;139(10):1253-7.
19. East EG, Pang JC, Kidwell KM, Jorns JM. Utility of estrogen receptor, progesterone receptor, and HER-2/neu analysis of multiple foci in multifocal ipsilateral invasive breast carcinoma. Am J Clin Pathol. 2015 Dec;144(6):952-9.
20. Inyang A, Thomas DG, Jorns J. Heterologous Liposarcomatous Differentiation in Malignant Phyllodes Tumor is Histologically Similar but Immunohistochemically and Molecularly Distinct from Well-differentiated Liposarcoma of Soft Tissue. Breast J. 2016 May;22(3):282-6.
21. Jorns JM, Kidwell KM. Sentinel Lymph Node Frozen-Section Utilization Declines After Publication of American College of Surgeons Oncology Group Z0011 Trial Results With No Change in Subsequent Surgery for Axillary Lymph Node Dissection. Am J Clin Pathol. 2016 Jul;146(1):57-66.
22. Jorns JM. Papillary Lesions of the Breast: A Practical Approach to Diagnosis. Arch Pathol Lab Med. 2016 Oct;140(10):1052-9.
23. Park J, Wysocki RW, Amoozgar Z, Maiorino L, Fein MR, Jorns J, Schott AF, Kinugasa-Katayama Y, Lee Y, Won NH, Nakasone ES, Hearn SA, Küttner V, Qiu J, Almeida AS, Perurena N, Kessenbrock K, Goldberg MS, Egeblad M. Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps. Sci Transl Med. 2016 Oct 19;8(361):361ra138. PMCID: PMC5550900
24. East EG, Zhao L, Pang JC, Jorns JM. Characteristics of a Breast Pathology Consultation Practice. Arch Pathol Lab Med. 2017 Apr;141(4):578-584.
25. Jorns JM. Extranodal Rosai-Dorfman Disease of the Breast. Breast J. 2017 Jan;23(1):105-107.
26. Mor-Vaknin N, Saha A, Legendre M, Carmona-Rivera C, Amin MA, Rabquer BJ, Gonzales-Hernandez MJ, Jorns J, Mohan S, Yalavarthi S, Pai DA, Angevine K, Almburg SJ, Knight JS, Adams BS, Koch AE, Fox DA, Engelke DR, Kaplan MJ, Markovitz DM. DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis. Nat Commun. 2017 Feb 06;8:14252. PMCID: PMC5303823
27. McCleskey BC, Epstein JI, Albany C, Hashemi-Sadraei N, Idrees MT, Jorns JM, Lu DY, Matoso A, Rais-Bahrami S, Schwartz LE, Ulbright TM, Gordetsky J. The Significance of Lymphovascular Invasion of the Spermatic Cord in the Absence of Cord Soft Tissue Invasion. Arch Pathol Lab Med. 2017 Jun;141(6):824-829.
28. Jorns JM, Daignault S, Sabel MS, Myers JL, Wu AJ. Frozen sections in patients undergoing breast conserving surgery at a single ambulatory surgical center: 5 year experience. Eur J Surg Oncol. 2017 Jul;43(7):1273-1281.
29. Briski LM, Jeffries DO, Jorns JM. Primary atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDL) of the breast. Breast J. 2018 May;24(3):400-401.
30. Muller KE, Jorns JM. Metaplastic Carcinoma With Extensive Chondromyxoid Differentiation Arising in Association With Microglandular Adenosis. Int J Surg Pathol. 2017 Sep;25(6):513-514.
31. Gordetsky J, Sanfrancesco J, Epstein JI, Trevino K, Xu H, Osunkoya A, Xiao GQ, Kao CS, Unger P, Hashemi-Sadraei N, Albany C, Jorns JM, Lu DY, Matoso A, Rais-Bahrami S, Schwartz LE, Ulbright TM, Idrees MT. Do Nonseminomatous Germ Cell Tumors of the Testis With Lymphovascular Invasion of the Spermatic Cord Merit Staging as pT3? Am J Surg Pathol. 2017 Oct;41(10):1397-1402.
32. Jeffries DO, Dossett LA, Jorns JM. Localization for Breast Surgery: The Next Generation. Arch Pathol Lab Med. 2017 Oct;141(10):1324-1329.
33. Abdelkader A, Jorns JM. Pleomorphic Lobular Carcinoma: A Controversially Aggressive Variant of Invasive Lobular Carcinoma of the Breast. Int J Surg Pathol. 2018 Aug;26(5):434-436.
34. East EG, Gast KM, Kuzon WM Jr, Roberts E, Zhao L, Jorns JM. Clinicopathological findings in female-to-male gender-affirming breast surgery. Histopathology. 2017 Dec;71(6):859-865.
35. Akagi NE, Jorns JM. Glycogen-Rich Clear Cell Carcinoma: A Rare Variant of Breast Carcinoma of Uncertain Significance. Int J Surg Pathol. 2018 Sep;26(6):530-531.
36. Griggs JJ, Hamilton AS, Schwartz KL, Zhao W, Abrahamse PH, Thomas DG, Jorns JM, Jewell R, Saber ME, Haque R, Katz SJ. Discordance between original and central laboratories in ER and HER2 results in a diverse, population-based sample. Breast Cancer Res Treat. 2017 Jan;161(2):375-384. PMCID: PMC5902386
37. Briski LM, Jorns JM. Primary Breast Atypical Lipomatous Tumor/ Well-Differentiated Liposarcoma and Dedifferentiated Liposarcoma. Arch Pathol Lab Med. 2018 Feb;142(2):268-274.
38. Muller KE, Roberts E, Zhao L, Jorns JM. Isolated Atypical Lobular Hyperplasia Diagnosed on Breast Biopsy: Low Upgrade Rate on Subsequent Excision With Long-Term Follow-up. Arch Pathol Lab Med. 2018 Mar;142(3):391-395.
39. Muller KE, Zhao L, Jorns JM. Metastatic and hematolymphoid neoplasms involving the breast: 20-year experience at a Tertiary Center. Breast J. 2018 Jul;24(4):680-682.
40. Solanki MH, Derylo AF, Jorns JM. Invasive Mammary Carcinoma With Mixed Invasive Papillary and Glycogen Rich Clear Cell Features. Int J Surg Pathol. 2018 Sep;26(6):569-572.
41. East EG, Gabbeart M, Roberts E, Zhao L, Jorns JM. A rapid triage protocol to optimize cold ischemic time for breast resection specimens. Ann Diagn Pathol. 2018 Jun;34:94-97.
42. Rooney SP, Hoffman S, Perrin JC, Milliron KJ, Nees AV, Jorns JM. Patient-friendly pathology reports for patients with breast atypias. Breast J. 2018 Sep;24(5):855-857.
43. Savage JL, Jeffries DO, Noroozian M, Sabel MS, Jorns JM, Helvie MA. Pleomorphic Lobular Carcinoma In Situ: Imaging Features, Upgrade Rate, and Clinical Outcomes. AJR Am J Roentgenol. 2018 Aug;211(2):462-467.
44. Asirvatham JR, Jorns JM, Zhao L, Jeffries DO, Wu AJ. Outcomes of benign intraductal papillomas diagnosed on core biopsy: a review of 104 cases with subsequent excision from a single institution. Virchows Arch. 2018 Dec;473(6):679-686.
45. Solanki MH, Derylo AF, Visotcky AM, Jorns JM. Encapsulated and solid papillary carcinomas of the breast: Tumors in transition from in situ to invasive? Breast J. 2019 May;25(3):539-541.
46. Kravtsov O, Jorns JM. Microglandular Adenosis and Associated Invasive Carcinoma. Arch Pathol Lab Med. 2020 Jan;144(1):42-46.
47. East EG, Roberts E, Zhao L, Jorns JM. Repeat Biomarker Status in Breast Resection Specimens With Controlled Cold Ischemic Time. Am J Clin Pathol. 2019 Nov 04;152(6):766-774.
48. Jorns JM. Breast Cancer Biomarkers: Challenges in Routine Estrogen Receptor, Progesterone Receptor, and HER2/neu Evaluation. Arch Pathol Lab Med. 2019 Dec;143(12):1444-1449.
49. Jorns JM, Kleer CG. Pathology of ductal carcinoma in situ: Features and diagnostic challenges Ductal Carcinoma in Situ and Microinvasive/Borderline Breast Cancer. 1 January 2015:39-49.
50. Moreno G, Jorns JM. Endosalpingiosis and other benign epithelial inclusions in breast sentinel lymph nodes. Breast J. 2020 Feb;26(2):274-275.
51. Gong X, Hou Z, Endsley MP, Gronseth EI, Rarick KR, Jorns JM, Yang Q, Du Z, Yan K, Bordas ML, Gershan J, Deepak P, Geethadevi A, Chaluvally-Raghavan P, Fan Y, Harder DR, Ramchandran R, Wang L. Interaction of tumor cells and astrocytes promotes breast cancer brain metastases through TGF-β2/ANGPTL4 axes. NPJ Precis Oncol. 2019;3:24. PMCID: PMC6776663
52. Arispe Angulo KR, Jawa Z, Visotcky A, Majidi SS, Chitambar CR, Jorns JM. A high mitotic score in breast cancer after neoadjuvant chemotherapy is predictive of outcome and associated with a distinct morphology. Histopathology. 2020 Apr;76(5):661-670.
53. Wang L, Jorns JM. Lymphocytic mastitis mimicking breast cancer in an elderly woman. Breast J. 2020 Jul;26(7):1414-1415.
54. Kravtsov O, Techawatanaset K, Cherian S, Jorns JM. Benign vascular lesions and angiolipomas of the breast: Radiologic-pathologic correlation. Breast J. 2020 Sep;26(9):1906-1908.
55. Singla N, Kunju LP, Jorns JM. Testicular Size Discrepancy in a Man Evaluated for Vasectomy. Am J Urol Res. 2016;1(1):8-11. PMCID: PMC7133769
56. Lu T, Jorns J, Patton M, Fisher R, Emmrich A, Doehring T, Gilat-Schmidt T, Ye DH, Yen T, Yu B. Deep UV fluorescence scanning microscopy for breast tumor margin detection Progress in Biomedical Optics and Imaging - Proceedings of SPIE. 2019;11229.
57. Arispe Angulo KR, Farooq A, Samra H, Weldemichael W, Anderson J, Jorns JM. Data-Driven Development of an Institutional "Gross-Only" Policy for the Examination of Select Surgical Pathology Specimens. Am J Clin Pathol. 2020 Sep 08;154(4):486-493.
58. Wang L, Jorns JM. Cystic neutrophilic granulomatous mastitis: Corynebacterium species-associated infection with distinct histology. Clin Microbiol Infect. 2021 Feb;27(2):236-237.
59. Czaja R, Wu R, Jorns JM. Breast Sentinel Lymph Node Frozen Section Practice: An Enterprise Audit as a Guide for Moving Forward. Arch Pathol Lab Med. 2021 Aug 01;145(8):1018-1024.
60. Lu T, Jorns JM, Patton M, Fisher R, Emmrich A, Doehring T, Schmidt TG, Ye DH, Yen T, Yu B. Rapid assessment of breast tumor margins using deep ultraviolet fluorescence scanning microscopy. J Biomed Opt. 2020 Nov;25(12). PMCID: PMC7688317
61. Statz E, Jorns JM. Cytokeratin 7, GATA3, and SOX-10 is a Comprehensive Panel in Diagnosing Triple Negative Breast Cancer Brain Metastases. Int J Surg Pathol. 2021 Aug;29(5):470-474.
62. Farooq A, Abdelkader A, Javakhishivili N, Moreno GA, Kuderer P, Polley M, Hunt B, Giorgadze TA, Jorns JM. Assessing the value of second opinion pathology review. Int J Qual Health Care. 2021 Mar 11;33(1).
63. Lang N, Saxena D, Yen T, Jorns J, Yu B, Ye DH. Breast cancer magnification-independent multi-class histopathology classification using dual-step model Progress in Biomedical Optics and Imaging - Proceedings of SPIE. 2021;11603.
64. Wang L, Asirvatham JR, Ma Y, Reisenbichler ES, Jorns JM. HER-2/neu-positive breast cancer neoadjuvant chemotherapy response after implementation of 2018 ASCO/CAP focused update. Breast J. 2021 Aug;27(8):631-637.
65. Asirvatham JR, Jorns JM. How Do Pathologists in Academic Institutions Across the United States and Canada Evaluate Sentinel Lymph Nodes in Breast Cancer? A Practice Survey. Am J Clin Pathol. 2021 Nov 08;156(6):980-988.
66. Moreno G, Molina M, Wu R, Sullivan JR, Jorns JM. Unveiling the histopathologic spectrum of MRI-guided breast biopsies: an institutional pathological-radiological correlation. Breast Cancer Res Treat. 2021 Jun;187(3):673-680.
67. Czaja R, Wu R, Jorns JM. Breast sentinel lymph node frozen section practice an enterprise audit as a guide for moving forward Archives of Pathology and Laboratory Medicine. August 2021;145(8):1018-1024.
68. Sun Y, Yang N, Utama FE, Udhane SS, Zhang J, Peck AR, Yanac A, Duffey K, Langenheim JF, Udhane V, Xia G, Peterson JF, Jorns JM, Nevalainen MT, Rouet R, Schofield P, Christ D, Ormandy CJ, Rosenberg AL, Chervoneva I, Tsaih SW, Flister MJ, Fuchs SY, Wagner KU, Rui H. NSG-Pro mouse model for uncovering resistance mechanisms and unique vulnerabilities in human luminal breast cancers. Sci Adv. 2021 Sep 17;7(38):eabc8145. PMCID: PMC8443188
69. Farooq A, Shponka V, Jorns JM. Amyloidosis of Breast: An uncommon mimic of fat necrosis Human Pathology Reports. November 2021;26.
70. Lu T, Jorns J, Patton M, Fisher R, Emmrich A, Gilat-Schmidt T, Ye DH, Yen T, Yu B. Texture analysis of deep ultraviolet fluorescence images for intraoperative assessment of breast tumor margins Optics InfoBase Conference Papers. 2021.
71. Ratiani M, Farooq A, Jorns J, Sheinin Y. Keratin 7 and ERBB2 Negative Mammary Paget Disease Without an Underlying in Situ and Invasive Carcinoma. Int J Surg Pathol. 2022 Aug;30(5):590-592.
72. Fernandez AI, Liu M, Bellizzi A, Brock J, Fadare O, Hanley K, Harigopal M, Jorns JM, Kuba MG, Ly A, Podoll M, Rabe K, Sanders MA, Singh K, Snir OL, Soong TR, Wei S, Wen H, Wong S, Yoon E, Pusztai L, Reisenbichler E, Rimm DL. Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue. JAMA Oncol. 2022 Apr 01;8(4):1-4. PMCID: PMC8814969
73. Puzyrenko A, Cortina CS, Jorns JM. New Challenges in the Differential Diagnosis of High-Grade Triple-Negative Breast Cancer and Serous Carcinoma. Int J Surg Pathol. 2022 Oct;30(7):728-733.
74. Muller K, Jorns JM, Tozbikian G. What's new in breast pathology 2022: WHO 5th edition and biomarker updates. J Pathol Transl Med. 2022 May;56(3):170-171. PMCID: PMC9119809
75. Sridhar N, Glisch C, Jawa Z, Chaudhary LN, Kamaraju S, Burfeind J, Charlson J, Chitambar CR, Jorns JM, Cheng YC. Androgen receptor expression in patients with triple negative breast cancer treated with neoadjuvant chemotherapy: a single institution study. J Cancer. 2022;13(8):2472-2476. PMCID: PMC9174868
76. Martinez EO, Jorns JM, Kong AL, Cortina CS. ASO Author Reflections: Rare Breast Cancer Subtypes and the Role for Precision Oncology. Ann Surg Oncol. 2022 Oct;29(10):6347-6348.
77. Martinez EO, Jorns JM, Kong AL, Kijak J, Lee WY, Huang CC, Cortina CS. Primary Breast Neuroendocrine Tumors: An Analysis of the National Cancer Database. Ann Surg Oncol. 2022 Oct;29(10):6339-6346. PMCID: PMC9464685
78. Johnson KM, Esselmann J, Purdy AC, Jorns JM. Patient Use of Pathology Reports via Online Portals. Arch Pathol Lab Med. 2022 Sep 01;146(9):1053-1055.
79. Martinez EO, Jorns JM, Kong AL, Kijak J, Lee WY, Huang CC, Cortina CS. ASO Visual Abstract: Primary Breast Neuroendocrine Tumors-An Analysis of the National Cancer Database. Ann Surg Oncol. 2022 Oct;29(10):6349.
80. Lu T, Jorns JM, Ye DH, Patton M, Fisher R, Emmrich A, Schmidt TG, Yen T, Yu B. Automated assessment of breast margins in deep ultraviolet fluorescence images using texture analysis. Biomed Opt Express. 2022 Sep 01;13(9):5015-5034. PMCID: PMC9484420
81. Gellings JA, Cortina CS, Jorns JM, Johnson MK, Huang CC, Kong AL. Annual cost-savings with the implementation of estrogen-receptor-only testing on Ductal Carcinoma in Situ specimens. Am J Surg. 2023 Feb;225(2):304-308.
82. Moreno GA, Molina MI, Eastwood D, Auer PL, Jorns JM. Contemporary evaluation of estrogen receptor and progesterone receptor expression in breast cancer-associated stroma. Breast Cancer Res Treat. 2022 Dec;196(3):453-461.
83. Onyenekwu CP, Czaja RC, Norui R, Hunt BC, Miller J, Jorns JM. Assessment of Quality of Frozen Section Services at a Large Academic Hospital Before and After Relocation. Am J Clin Pathol. 2022 Nov 03;158(5):655-663.
84. Lennerz JK, Pantanowitz L, Amin MB, Eltoum IE, Hameed MR, Kalof AN, Khanafshar E, Kunju LP, Lazenby AJ, Montone KT, Otis CN, Reid MD, Staats PN, Whitney-Miller CL, Abendroth CS, Aron M, Birdsong GG, Bleiweiss IJ, Bronner MP, Chapman J, Cipriani NA, de la Roza G, Esposito MJ, Fadare O, Ferrer K, Fletcher CD, Frishberg DP, Garcia FU, Geldenhuys L, Gill RM, Gui D, Halat S, Hameed O, Hornick JL, Huber AR, Jain D, Jhala N, Jorda M, Jorns JM, Kaplan J, Khalifa MA, Khan A, Kim GE, Lee EY, LiVolsi VA, Longacre T, Magi-Galluzzi C, McCall SJ, McPhaul L, Mehta V, Merzianu M, Miller SB, Molberg KH, Moreira AL, Naini BV, Nosé V, O’Toole K, Picken M, Prieto VG, Pullman JM, Quick CM, Reynolds JP, Rosenberg AE, Schnitt SJ, Schwartz MR, Sekosan M, Smith MT, Sohani A, Stowman A, Vanguri VK, Wang B, Watts JC, Wei S, Whitney K, Younes M, Zee S, Bracamonte ER. Ensuring remote diagnostics for pathologists: an open letter to the US Congress Nature Medicine. 2022.
85. Lennerz JK, Pantanowitz L, Amin MB, Eltoum IE, Hameed MR, Kalof AN, Khanafshar E, Kunju LP, Lazenby AJ, Montone KT, Otis CN, Reid MD, Staats PN, Whitney-Miller CL, Abendroth CS, Aron M, Birdsong GG, Bleiweiss IJ, Bronner MP, Chapman J, Cipriani NA, de la Roza G, Esposito MJ, Fadare O, Ferrer K, Fletcher CD, Frishberg DP, Garcia FU, Geldenhuys L, Gill RM, Gui D, Halat S, Hameed O, Hornick JL, Huber AR, Jain D, Jhala N, Jorda M, Jorns JM, Kaplan J, Khalifa MA, Khan A, Kim GE, Lee EY, LiVolsi VA, Longacre T, Magi-Galluzzi C, McCall SJ, McPhaul L, Mehta V, Merzianu M, Miller SB, Molberg KH, Moreira AL, Naini BV, Nosé V, O'Toole K, Picken M, Prieto VG, Pullman JM, Quick CM, Reynolds JP, Rosenberg AE, Schnitt SJ, Schwartz MR, Sekosan M, Smith MT, Sohani A, Stowman A, Vanguri VK, Wang B, Watts JC, Wei S, Whitney K, Younes M, Zee S, Bracamonte ER. Ensuring remote diagnostics for pathologists: an open letter to the US Congress. Nat Med. 2022 Dec;28(12):2453-2455.
86. Chervoneva I, Peck AR, Sun Y, Yi M, Udhane SS, Langenheim JF, Girondo MA, Jorns JM, Chaudhary LN, Kamaraju S, Bergom C, Flister MJ, Hooke JA, Kovatich AJ, Shriver CD, Hu H, Palazzo JP, Bibbo M, Hyslop T, Nevalainen MT, Pestell RG, Fuchs SY, Mitchell EP, Rui H. High PD-L2 Predicts Early Recurrence of ER-Positive Breast Cancer. JCO Precis Oncol. 2023 Jan;7:e2100498. PMCID: PMC9928763
87. Robbins CJ, Fernandez AI, Han G, Wong S, Harigopal M, Podoll M, Singh K, Ly A, Kuba MG, Wen H, Sanders MA, Brock J, Wei S, Fadare O, Hanley K, Jorns J, Snir OL, Yoon E, Rabe K, Soong TR, Reisenbichler ES, Rimm DL. Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry. Mod Pathol. 2023 Jan;36(1):100032. PMCID: PMC10278086
88. Chaudhary LN, Jorns J, Sun Y, Cheng YC, Kamaraju S, Burfeind J, Gonyo M, Kong A, Patten C, Yen T, Cortina C, Carson E, Johnson N, Bergom C, Tsaih SW, Banerjee A, Wang Y, Chervoneva I, Weil E, Chitambar CR, Rui H. Frequent Upregulation Of HER2 Protein In Hormone Receptor-Positive HER2-Negative Breast Cancer After Short-Term Neoadjuvant Endocrine Therapy. Res Sq. 2023 Apr 07. PMCID: PMC10104267
89. Lu T, Jorns JM, Ye DH, Patton M, Gilat-Schmidt T, Yen T, Yu B. Analysis of deep ultraviolet fluorescence images for intraoperative breast tumor margin assessment Progress in Biomedical Optics and Imaging - Proceedings of SPIE. 2023;12368.
90. Jorns JM, Farooq A, Puzyrenko A, Jarzembowski J, Thike AA, Nasir NDM, Ng CCY, Liu W, Lee JY, Lim AH, Guan P, Teh BT, Tan PH. Giant juvenile fibroadenomas with and without prominent pseudoangiomatous stromal hyperplasia (PASH)-like change: clinicopathological and molecular characteristics Histopathology. 2023.
91. Jorns JM, Farooq A, Puzyrenko A, Jarzembowski J, Thike AA, Nasir NDM, Ng CCY, Liu W, Lee JY, Lim AH, Guan P, Teh BT, Tan PH. Giant juvenile fibroadenomas with and without prominent pseudoangiomatous stromal hyperplasia (PASH)-like change: clinicopathological and molecular characteristics. Histopathology. 2023 Sep;83(3):357-365.
92. Chaudhary LN, Jorns JM, Sun Y, Cheng YC, Kamaraju S, Burfeind J, Gonyo MB, Kong AL, Patten C, Yen T, Cortina CS, Carson E, Johnson N, Bergom C, Tsaih SW, Banerjee A, Wang Y, Chervoneva I, Weil E, Chitambar CR, Rui H. Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy. Breast Cancer Res Treat. 2023 Oct;201(3):387-396. PMCID: PMC10795510
93. To T, Lu T, Jorns JM, Patton M, Schmidt TG, Yen T, Yu B, Ye DH. Deep learning classification of deep ultraviolet fluorescence images toward intra-operative margin assessment in breast cancer. Front Oncol. 2023;13:1179025. PMCID: PMC10313133
94. Bacos JT, Doren E, D'Souza A, Jorns J, Kong A. Surgical Management of Breast Amyloidosis. Clin Breast Cancer. 2023 Aug;23(6):e359-e367.
95. Lu T, Jorns JM, Ye DH, Patton M, Gilat-Schmidt T, Yen T, Yu B. Analysis of Deep Ultraviolet Fluorescence Images for Intraoperative Breast Tumor Margin Assessment. Proc SPIE Int Soc Opt Eng. 2023;12368. PMCID: PMC10249647
96. Wadhwa A, Majidi SS, Reimer S, Bogachkov A, Dernell C, Astle J, Jorns JM. Axillary node evaluation and biopsy: Predictors of malignancy based on sonographic morphology and mode of detection Clinical Imaging. December 2023;104.
97. Desouki MM, Hagemann IS, Khoury T, Fadare O, Bhargava R, Clark JL, Deavers MT, Jorns JM, Khan A, Cosar EF, Karabakhtsian RG, Klein ME, Pinto A, Ali M. Selective breast/gynecologic pathology fellowship training in the United States: Experience of program directors. Acad Pathol. 2024;11(1):100103. PMCID: PMC10877681
98. Cobb AN, Czaja R, Jorns J, Cortina CS. Breast Cancer Subtypes: Clinicopathologic Features and Treatment Considerations Current Breast Cancer Reports. 2024.
99. Dernell C, Astle J, Bogachkov A, Reimer S, Wadhwa A, Majidi SS, Canales B, Jorns JM. Improving resource utilization: Axillary lymph node core biopsy triaging for lymphoma. Am J Clin Pathol. 2024 Sep 03;162(3):227-232.
100. Jorns JM, Sun Y, Kamaraju S, Cheng YC, Kong A, Yen T, Patten CR, Cortina CS, Chitambar CR, Rui H, Chaudhary LN. Divergent Cellular Expression Patterns of PD-L1 and PD-L2 Proteins in Breast Cancer. J Pers Med. 2024 Apr 29;14(5). PMCID: PMC11121947
101. Ghahfarokhi SS, To T, Jorns J, Yen T, Yu B, Ye DH. Deep Learning for Automated Detection of Breast Cancer in Deep Ultraviolet Fluorescence Images with Diffusion Probabilistic Model Proceedings - International Symposium on Biomedical Imaging. 2024.
102. Rogers C, Zeien S, Puccetti K, Jorns JM, Kong AL, Cherian S, Cortina CS. Examining the false-negative rate of a negative axillary node ultrasound-guided core needle biopsy in breast cancer patients undergoing upfront surgery. Am J Surg. 2025 Jan;239:116047. PMCID: PMC11650375
103. Wadhwa A, Majidi SS, Reimer S, Bogachkov A, Dernell C, Astle J, Jorns JM. Axillary node evaluation and biopsy: Predictors of malignancy based on sonographic morphology and mode of detection. Clin Imaging. 2023 Oct 25;104:110014.
104. Jain PV, Molina M, Moh M, Bishop E, Rader JS, Jorns JM. Immunohistochemistry in the Differential Diagnosis of Triple Negative Breast Carcinoma and High-grade Serous Carcinoma: Old and New Markers. Appl Immunohistochem Mol Morphol. 2024 Nov-Dec 01;32(10):456-461.
105. Bo AY, Cheng YC, George B, Kilari D, Thompson JR, Jorns JM. Online Portal Use of Pathology Reports in Patients With Solid Tumors. Arch Pathol Lab Med. 2024 Dec 26.
106. Kamaraju S, Fowler AM, Tarima S, Chaudhary LN, Burkard ME, Giever T, Cheng YC, Parkes A, Lange CA, Pipp-Dahm M, Hegeman R, Siddiqui N, Stella A, Rajguru S, Twaroski K, Zurbriggen L, Jorns JM, Rui H, Keigley QJ, Perlman SB, Salem K, Bradshaw TJ, Sahmoud T, Wisinski K. A Phase II Trial of Onapristone and Fulvestrant for Patients With ER+ and HER2- Metastatic Breast Cancer. Clin Breast Cancer. 2024 Dec 10.
 
Books, Chapters, and Reviews
1. Jorns JM, Breslin TM Advanced Therapy of Breast Disease, Chapter 72 (Paget Disease); Peoples Medical Publishing House, 2012; 1109-1118.
2. Jorns JM, Kleer CG Ductal Carcinoma in Situ and Microinvasive/Borderline Breast Cancer, Chapter 4 (Pathology of Ductal Carcinoma in Situ: Features and Diagnostic Challenges); Springer, 2015; 39-49.